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Edited by Judit OvadiAbstract Septins are a family of conserved cytoskeletal GTP-
ases implicated in a variety of cellular functions such as
cytokinesis and vesicle traﬃcking. Here, we report identiﬁcation
of an yet uncharacterized septin, Sept11, in septin complexes
puriﬁed from porcine brain. The transcripts were detected in all
tested tissues except leukocytes. A Sept11 mutant with appar-
ently reduced GTPase activity did not form ﬁlaments in the
transient expression system using COS7 cells. By Western blot
analysis using a speciﬁc antibody, Sept11 was detected in various
cell lines as well as brain tissues. Septin complexes immunois-
olated from porcine brain with anti-Sept9 and anti-Sept11
antibodies were found to contain diﬀerent Sept9 isoforms based
on SDS–PAGE analyses followed by silver-staining and Western
blotting. Immunoﬂuorescent study revealed cell type-dependent
intracellular localization of the protein; Sept11 was colocalized
dominantly with microtubules and actin stress ﬁbers in HMEC
cells and REF52 cells, respectively, and their ﬁlamentous
distribution was dependent on the cytoskeleton structures with
which the protein is colocalized. Sept11 partially colocalized with
stress ﬁbers and microtubules in HeLa cells.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Septins, a family of heteropolymeric ﬁlament-forming pro-
teins, were originally discovered in yeast to be essential for
cytokinesis and have since been identiﬁed in most eukaryotic
organisms, with the exception of plants (for review see [1–5]).
Septins have a 25% or closer identity over their entire length
and sequence similarity is greatest in the central domain which
contains guanine nucleotide (nt) interactive motifs homolo-* Corresponding authors. Fax: +81-568-88-0829.
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doi:10.1016/j.febslet.2004.05.030gous to those of ras-related small GTPases. In addition to the
conserved central domain, most septins have divergent N- and
C-terminal domains, many of which contain a predicted
coiled-coil region possibly involved in protein–protein inter-
action. Although the ras-related small GTPases function as
signal transducing molecular switches through GTP/GDP-
exchange and GTP-hydrolysis, physiological signiﬁcance of
mammalian septins is largely unknown. In addition to the
important roles of septins involved in cytokinesis, the accu-
mulating biochemical and cell biological observations suggest
various physiological roles of septins such as cytoskeletal
polymers and scaﬀolds for assembly of signaling complexes
(for review see [1–5]). As for mammalian cells, 12 septin genes
have so far been identiﬁed mainly based on random sequenc-
ing projects and some septins represent alternative splicing
forms (reviewed in [5,6]). By using mass spectrometry analyses,
we here identiﬁed a septin, Sept11, in septin complexes puriﬁed
from porcine brain, and carried out biochemical and cell bio-
logical characterization.2. Materials and methods
2.1. Materials
Fresh porcine brains were purchased from local slaughterhouse. SP-
Sepharose fast ﬂow resin, MonoS (8 ml) and MonoQ (1 ml) were from
Pharmacia Biotech Inc. Prepacked hydroxyapatite column (1-ml
Econo-Pac CHT-II cartridge) was from Bio-Rad Inc.
2.2. Plasmid construction
Human Sept11 was produced by PCR with Marathon-Ready cDNA
(human brain) (Clontech Inc.). A48Sept11, a Sept11 mutant with a
point mutation (Gly48 to Ala) in the G1 box of the GTPase region,
was prepared using QuickChange Site-directed Mutagenesis Kits
(Stratagene Inc.). The constructs were veriﬁed by DNA sequencing.
Sept11 cDNAs were subcloned into pMal, pGEX4T3, or pRK5 vector
containing Myc- or Flag-tag.
2.3. Identiﬁcation of proteins by mass spectrometry
Protein identiﬁcation was performed by mass spectrometry com-
bined with sequence database searches. Protein bands excised from a
Coomassie blue-stained polyacrylamide gel were rinsed, reduced, S-
alkylated and then incubated with trypsin. The resulting tryptic pep-
tide mixtures were directly analyzed by LC–MS/MS.
2.4. Northern blot analysis
A human multiple tissue Northern blot (Clontech) was hybridized in
accordance with the manufacturer’s instructions using a [a-32P]dCTP-
labeled cDNA probe encompassing nt 2045–3795 of Sept11 sequence.blished by Elsevier B.V. All rights reserved.
Fig. 1. Identiﬁcation of Sept11 in septin complexes puriﬁed from
porcine brain. (A) Coomassie blue staining of the septin complexes
puriﬁed from porcine brain after SDS–PAGE (10% gel). A 48-kDa
band and septins identiﬁed by mass spectrometry analyses are marked.
Molecular size markers were shown on the left. (B) Alignment of the aa
sequence of Sept11. The aa sequences underlined are those identiﬁed in
mass spectrometry. Three conserved regions (G1, G3, and G4) in the
GTPase domain were boxed. (C) Diagram of Sept11 showing N- and
C-terminal variable regions as well as a central GTPase domain. Total
homologies as well as regional ones between Sept11 and 10 mamma-
lian septins so far identiﬁed are shown. (D) Northern blot analyses. A
nylon membrane containing human mRNAs (2 lg each) from diﬀerent
tissues was used. Molecular sizes of RNA standards are indicated on
the left.
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isolation
Using the glutathione S-transferase-fused Sept11 fragment (amino
acid, aa, 366–429) expressed in E. coli as the antigen, a rabbit poly-
clonal antibody speciﬁc for Sept11 (anti-Sept11-C) was produced and
aﬃnity-puriﬁed. An antibody for Sept9 (anti-Sept9, previously referred
to as MSF, anti-mixed lineage leukemia septin-like fusion) was also
produced and aﬃnity-puriﬁed as described [7]. Western blot analysis
was done and immunoreactive bands were visualized as described [7].
For immunoaﬃnity isolation, the high speed supernatant fraction of
porcine brain was prepared as described [8]. Septin complexes were
isolated with CNBr-activated Sepharose 4B beads coupled with anti-
Sept11-C or anti-Sept9 antibodies. Proteins bound to the beads were
eluted with 0.2 M glycine–HCl (pH 2.5) and analyzed by SDS–PAGE
(10%) followed by silver-staining or Western blotting.
2.6. Cell culture, transfection and immunoﬂuorescence
A variety of cell lines were cultured essentially as described [7]. In
some experiments, cells were treated with 5 lM cytochalasin B for 10
min or 10 ng/ml demecolcine for 100 min. For immunoﬂuorescence
analyses, cells were ﬁxed in 3.7% formaldehyde, then treated with 0.2%
Triton X-100. To detect Sept11, anti-Sept11-C was used as the primary
antibody. To visualize Myc-tag, Flag-tag, actin or tubulin, cells were
reacted with 9E10, M2 (Sigma Inc.), rhodamine–phalloidin or anti-
tubulin monoclonal antibody (Sigma), respectively. Alexa 488-labeled
or Cy3-labeled antibody (Molecular Probes Inc.) was used as a sec-
ondary one. When analyzing the cells, we used an Olympus LSM-
GB200 confocal microscope.
2.7. Expression and puriﬁcation of recombinant proteins
Sept11 and A48Sept11 were expressed in E. coli as maltose-binding
protein (MBP)-fusion proteins and puriﬁed in accordance with the
manufacturer’s instructions. The recombinant proteins were released
from the beads by cleavage with Factor Xa. Purity of the protein
preparations was conﬁrmed on Coomassie blue-stained SDS–poly-
acrylamide gels.
2.8. GTPase activity and [a-32P]GTP-binding assays
The GTPase activity was estimated by the liberation of 32Pi from
[c-32P]GTP in the presence of 10 mM MgCl2 and 100 lM GTP as
described [9]. For [a-32P]GTP-binding analysis, 1 lM (50 pmol)
recombinant Sept11 or the A48 mutant was incubated with 10 lM [a-
32P]GTP in the presence of 10 lM MgCl2 for 15 min at 30 C as de-
scribed [9]. After terminating the reaction by adding MgCl2 to a ﬁnal
concentration of 10 mM, Sept11 and the A48 mutants were precipi-
tated with anti-Sept11-C-coupled protein G agarose. After washing the
beads and denaturation of the bound proteins, eluted nt were analyzed
by thin layer chromatography as described [10].3. Results and discussion
3.1. Identiﬁcation of Sept11 in porcine brain septin complexes
In the course of study to elucidate the physiological sig-
niﬁcance of Sept9, which we referred to as MSF previously
[7], we wanted to identify the components of septin com-
plexes containing Sept9. For this purpose, we puriﬁed Sept9-
containing septin complexes in brain tissues. The septin
complexes were puriﬁed from porcine brain by successive
column chromatographies using SP-Sepharose fast ﬂow,
MonoS, MonoQ and a hydroxyapatite CHT-II, as described
[8]. Sept9 in eluted column fractions was monitored by
Western blotting and Sept9-enriched fractions were collected
at each column chromatography step. The resultant Sept9-
enriched fractions are most likely to contain some physio-
logical septin complexes even though the puriﬁed complexes
may not cover all existing brain septin complexes. To
identify components in the puriﬁed septin complexes, mass
spectrometry of tryptic digests (LC–MS/MS analyses) wasperformed, and the complexes were found to contain a va-
riety of septins (Fig. 1A). In the course of the analyses, a
protein band with molecular mass of 48 kDa was subjected
to LC–MS/MS analyses. Consequently, the analyzed pep-
tides consisted of those from a mixture of at least two
proteins (data not shown). The aa sequences of a group of
the digested peptides were found to be derived from Sept6
(data not shown). When database analyses of the aa se-
quences of remaining peptides were done, all of their se-
quences completely matched with FLJ10849 (GenBank
Accession No. AK001711) (Fig. 1B). The deduced aa se-
quence of FLJ10849 possessed clear sequence similarity to
septins in the central GTPase domain, and was highly ho-
mologous to Sept6 and Sept8 over the entire length
(Fig. 1C). FLJ10849 was recently referred to as Sept11 [5],
although its biochemical and cell biological characterization
has not been carried out. As shown in Fig. 1D, Northern
blot analysis revealed that Sept11 is widely expressed in all
tested tissues except leukocytes, and transcribed as various
combinations of 6.5, 3.0 and 2.0 kb mRNAs in tissue-
dependent manner.
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Sept11 in COS cells
GTPase activity is possible to play a role for the ﬁlamentous
structure of Sept2, while it is not required for polymer forma-
tion of Sept9 [7]. To test if the GTPase activity is essential for
the ﬁlament-forming ability of Sept11, we introduced a muta-
tion (Gly48 to Ala) in the G1 box of the GTPase region. MBP-
fused Sept11 and the mutant, A48Sept11, were expressed in
E. coli and puriﬁed (Fig. 2A). The GTPase activity of Sept11
and A48Sept11 was determined by measuring production of
free phosphate released from [c-32P]GTP as described [9]. It is
to be noted that the GTPase assay used here was composed of
two steps: [c-32P]GTP/GDP exchange and hydrolysis of bound
[c-32P]GTP to GDP. As depicted in Fig. 2B, A48Sept11 showed
a highly reduced in vitro GTPase activity under conditions
where Sept11 has the activity, although the possibility that the
reduced GTPase activity is due to the denaturation of the
protein cannot be ruled out. The speciﬁc activities were calcu-Fig. 2. Eﬀects of a GTPase-deﬁcient mutation in G1 box on the ﬁla-
ment-forming ability of Sept11. (A) Coomassie blue staining of puri-
ﬁed MBP-Sept11 (WT) and MBP-A48Sept11 (GA). Molecular size
markers (Da) were shown on the left. (B) Time course of in vitro
GTPase activity of Sept11 (WT) or A48Sept11 (GA) was examined.
Data are means S.D. of three separate experiments. (C) Puriﬁed re-
combinant Sept11 (WT) and A48Sept11 (GA) (1 lM) were labeled
with 10 lM [a-32P]GTP and the bound radioactive nt were eluted from
the proteins, resolved by thin-layer chromatography and counted. The
positions of GDP and GTP standards as well as the origin are indi-
cated. The results shown are representatives of three independent ex-
periments. (D) COS7 cells were transfected with pRK5-Myc-Sept11 or
-A48Sept11. After 24 h of transfection, these cells were stained using
9E10 antibody. (E) COS7 cells were double-transfected with pRK5-
Myc-Sept11 and pRK5-Flag-A48Sept11. After 24 h of transfection,
cells were double-stained using the anti-Myc polyclonal (left) and M2
antibodies (middle). The merged image is also shown (right). Bar,
20 lm.lated to be 0.115 0.01 and 0.0164 0.004 mmol Pi/mol of
protein/min for Sept11 and A48Sept11, respectively. There are
two possibilities for the apparent inhibition of the GTPase
activity of A48Sept11; one is due to the reduced GTP-binding
to the protein and another is reduced hydrolysis of bound GTP
to GDP. When [a-32P]GTP-binding activity of A48Sept11 was
compared to that of Sept11 by thin layer chromatography, both
proteins were found to bind almost equal amount of [a-
32P]GTP: 5.2% of wild-type and 4.7% of the mutant bound
[a-32P]GTP (Fig. 2C). Although only limited portion of the
used proteins interacted with guanine nt, these results suggest
that A48Sept11 possesses GTP-binding ability indistinguish-
able from that of Sept11 but lost the GTP-hydrolysis activity.
When Sept11 and A48Sept11 were individually overexpres-
sed in COS7 cells, the former formed ﬁlament structure while
the latter had signiﬁcantly abolished ﬁlament-forming ability
(Fig. 2D). Endogenous Sept11 was localized as a short ﬁla-
mentous pattern in COS7 cells similar to that observed in HeLa
cells (see Fig. 5A), although it should be noted that the staining
pattern of Sept11 was not overlapping with stress ﬁbers, mi-
crotubules and vimentin intermediate ﬁlaments.2 It should be
noted that the ﬁlament structure observed in COS7 cells ex-
pressing Myc-Sept11 is likely to be homopolymers which are
diﬀerent from the native heteropolymeric septin ﬁlaments.
Despite the above possibility, expressed Sept11 was likely to
have ﬁlament-forming and/or lateral association capability. It
is notable that A48Sept11 was not incorporated into the ﬁla-
ment composed of Sept11, and the ﬁlament structure by Sept11
and aggregates composed of A48Sept11 are independently
present in cells expressing them (Fig. 2E). These phenotypes
were very similar to those observed in the case of Sept2 as
described [7]. Taken together, these results suggest that GTP-
hydrolysis activity is required for polymer formation of Sept11,
although the possibility that A48Sept11 was aggregated due to
the mutation-mediated abnormal folding cannot be ruled out.
Since it has been recently reported that the majority of septin
complexes in S. cerevisiae do not exchange guanine nt [12], the
physiological importance of GTPase activity of Sept11 in
hetero-septin complexes remains to be elucidated.
3.3. Detection of Sept11 in various cell lines using a speciﬁc
antibody
We next prepared a rabbit polyclonal antibody, anti-Sept11-
C, against the C-terminal 66 aa of Sept11, and aﬃnity-puriﬁed
it on a column to which the antigen had been conjugated.
Speciﬁcity of anti-Sept11-C was conﬁrmed with various septin
proteins overexpressed in COS7 cells. As shown in Fig. 3A,
anti-Sept11-C speciﬁcally recognized Sept11 in Western blot
analyses. As other septins including Sept6 and Sept8, which
are highly homologous to Sept11 (Fig. 1C), were not recog-
nized by the antibody, we concluded that the antibody is
speciﬁc for Sept11. We next did a Western blot analysis to
detect endogenous Sept11 in rat brain homogenates and ly-
sates of various mammalian cell lines, including HeLa, ﬁbro-
blast REF52 and mammary gland HMEC cells (Fig. 3B). In
the cell lysates tested, a protein with molecular mass of
48 kDa, coincident with that of Sept11, was observed. The
high expression of Sept11-mRNA in kidney and relatively low2 Localization of Sept11 in COS cells, and characterization of
anti-Sept6 and anti-Sept7 will be described in detail elsewhere.
Fig. 3. Characterization of an aﬃnity-puriﬁed antibody for Sept11. (A)
Lysates from COS7 cells transiently expressing Myc-tagged Sept9a,
Sept9b, Sept9c, Sept4a, Sept2, Sept7, Sept11, and Sept8 were separated
on a 10% polyacrylamide gel and then subjected to Western blotting,
using anti-Sept11-C (upper panel) or 9E10 (lower panel). (B) Lysates
(30 lg of each) of HMEC, Swiss3T3, REF52, NIH3T3, MDCK,
HeLa, COS7, G361, Saos2, Neuro2a (N2A), C6D6 cells and rat brain
were subjected to SDS–PAGE (10% gel) followed by Western blotting
using anti-Sept11-C. Molecular size markers were shown on the left
side of each panel.
Fig. 4. Immunoisolation of Sept11- and Sept9-containing septin
complexes from porcine brain high speed supernatant. Septin com-
plexes isolated with Sepharose 4B beads coupled with anti-Sept9 an-
tibody (left lane of each panel) and anti-Sept11-C antibody (right lane
of each panel) were analyzed by silver-staining (A) or Western blotting
with anti-Sept9 (B) and anti-Sept11-C (C).
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MDCK, imply some role of Sept11 in the kidney functions
such as tubule transport and glomerular ultraﬁltration. In
Fig. 3A, anti-Sept11-C did not visualize endogenous Sept11 in
COS cells under the condition used, since the expression levels
of Myc-Sept11 were very high. Preincubation of the antibody
with recombinant Sept11 selectively inhibited the immunore-
activity (data not shown).
3.4. Analyses of septin complexes immunoisolated with
anti-Sept11-C or anti-Sept9 antibody
Presence of a variety of septins in brain implies the presence
of various functional septin complexes containing diﬀerent
polypeptides. Respective septin complexes may be localized in
diﬀerent intracellular places and are assembled to accomplish
diﬀerent biological processes. We thus tested if CNBr-activated
Sepharose 4B beads coupled with anti-Sept11-C or anti-Sept9
immunoisolate diﬀerent septin complexes from the porcine
brain high speed supernatant prepared as described [8].
As shown in Fig. 4A, silver-staining patterns of the protein
complexes isolated with anti-Sept11-C–Sepharose 4B and anti-
Sept9–Sepharose 4B were similar but clearly diﬀerent. Espe-
cially, a protein band with a molecular mass of 75 kDa was
detected only in anti-Sept9–Sepharose 4B-binding complexes
(Fig. 4A). When Western blot analysis of the isolated immu-
nocomplexes was done, the 75-kDa band was found to con-tain a Sept9 isoform (Fig. 4B). A Sept9 variant with 66 kDa
and Sept11 was detected in both immunoisolated complexes
(Fig. 4B and C). These results suggest that there are at least two
diﬀerent septin complexes in porcine brain tissues, although the
possibility that a region unique to the Sept9 isoform with a
higher molecular mass masks the Sept11 epitope in the septin
complexes cannot be excluded. The major bands with 50 kDa
observed in the silver-stained gel are likely to be composed of
septins or septin-binding protein(s) yet unidentiﬁed in the
present study. Actually, Sept6 and Sept7 that constitute the
main septin framework in mouse brain and HeLa cells [13] were
detected in the major band by Western blotting analyses1 (data
not shown). On the other hand, rabbit IgG released from the
antibody-coupled beads was not detected in Western blotting
with anti-rabbit IgG raised in donkey (data not shown).
The Sec6/8 (or exocyst) complex is thought to be essential
for secretory vesicle targeting and docking, and has so far been
reported to form large complexes with septin ﬁlaments [14].
Sept5 was also reported to bind directly with a SNARE pro-
tein syntaxin 1 and regulate exocytosis [15]. We thus asked if
Sec6, Sec8 and syntaxin are included in the septin complexes
isolated with anti-Sept9- or anti-Sept11-C-conjugated beads.
When Western blot analyses were performed with speciﬁc
antibodies for Sec6 (mouse monoclonal 9H5 clone, Calbio-
chem Inc.), Sec8 (mouse monoclonal 14G1 clone, Stressgen
Biotech. Corp.) and syntaxin (goat polyclonal, Santa Cruz
Inc.), these proteins were not detected in the isolated septin
complexes (data not shown), maybe due to the possibly
stringent puriﬁcation procedures used in the present study.
Alternatively, Sec6/8 and syntaxin may interact with septin
complexes diﬀerent from those isolated here.
3.5. Sept11 colocalizes with cytoskeletons in cell type-speciﬁc
manner
Mammalian septin organization is thought to be related to
actin ﬁlament structures and functions. Several septins have
been reported to localize along with actin ﬁlaments
[11,13,16,17], while Sept9 distributes along microtubules as
well as actin ﬁlaments [7,17]. We examined the subcellular
localization of Sept11 in HeLa, HMEC and REF52 cells, using
a confocal microscope. Interestingly, the localization patterns
Z. Dioszeghy et al. / FEBS Letters 568 (2004) 83–88 87of Sept11 were distinct among cell types tested. In HeLa cells,
Sept11 was present in short ﬁlamentous structures and partly
colocalized with stress ﬁbers (Fig. 5A). This localization was
similar to that of Sept2 in NIH3T3 cells [13]. Double-staining
with tubulin revealed some overlap between Sept11 and the
cytoskeleton (Fig. 5A). In HMEC cells, signiﬁcant colocal-
ization of Sept11 with microtubule networks was observed
(Fig. 5B,a–c), while characteristic localization of Sept11 along
with actin stress ﬁbers was seen in REF52 cells (Fig. 5C,a–c).
We next asked if Sept11 colocalizes with another major cyto-
skeleton, vimentin, in HeLa, HMEC and REF52 cells. Dou-
ble-staining showed no apparent codistribution of Sept11 with
vimentin ﬁlaments in these cells (data not shown). Since septin
ﬁlaments are composed of hetero-septin molecules, it is
tempting to speculate that Sept11 functions, in harmony with
other septin molecules, to control actin- and/or tubulin-
dependent cellular events.Fig. 5. Localization of Sept11 in HeLa, HMEC and REF52 cells. (A)
HeLa cells were double-stained using anti-Sept11-C (a,d) and rhoda-
mine–phalloidin (b) or an anti-tubulin antibody (e). The merged image
was also shown (c,f). (B,C) HMEC cells (B) and REF52 cells (C) were
double-stained using anti-Sept11-C (a) and an anti-tubulin antibody
(B,b) or rhodamine–phalloidin (C,b). The merged image was shown
(c). Eﬀects of treatment with cytochalasin B (d,e) or demecolcine (f,g)
on the ﬁlamentous distributions of Sept11 (d,f), F-actin (e) and mi-
crotubules (g) in the cells. (D) Staining patterns of microtubules (a,c)
and F-actin (b,d) in the untreated HMEC (a,b) and REF52 (c,d) cells.
Bar, 20 lm.The structural relationships among actin ﬁlaments, micro-
tubules and Sept11 were further examined using reagents
known to disrupt microtubule or actin ﬁlament structure.
When HMEC cells were treated for 15 min with 5 lM cyto-
chalasin B (Sigma), a speciﬁc inhibitor of actin polymerization,
the ﬁbrous distribution of Sept11 was still observed under the
conditions where actin ﬁlaments were disrupted (Fig. 5B,d and
e). When the cells were treated for 100 min with 10 ng/ml
demecolcine (Sigma), a speciﬁc inhibitor of tubulin polymeri-
zation, the ﬁbrous distribution of Sept11 as well as microtu-
bules was disrupted (Fig. 5B,f and g). These results suggest
that Sept11 interacts with microtubules in HMEC cells as is
the case of Sept9 [7]. On the other hand, treatment of REF52
cells with cytochalasin B induced disruption of Sept11-con-
taining septin ﬁlaments as well as stress ﬁbers (Fig. 5C,d and
e). When the cells were treated with demecolcine, the ﬁbrous
distribution of Sept11 was still observed under the conditions
where microtubules were disrupted (Fig. 5C,f and g). These
results suggest that Sept11 interacts with stress ﬁbers in REF52
cells. It is tempting to speculate that cell- or tissue type-speciﬁc
interaction between Sept11-containing septin complexes and
cytoskeletons might aﬀect the cytoskeletal dynamics and/or
septin functions in individual cells or tissues. In Fig. 5D,
staining patterns of microtubules (a and c) and F-actin (b and
d) in the untreated HMEC (a and b) and REF52 (c and d) cells
were shown.
In the present study, we found that a yet uncharacterized
member of septin family, Sept11, is widely expressed in
mammalian tissues and distributes along with cytoskeletons
in cell type-speciﬁc manner. The function of Sept11 remains
to be clariﬁed, although some septins have been reported to
be involved in cytokinetic events [7,11,16,17]. The presence
of a variety of septins in brain means that they are likely to
play some roles in yet unidentiﬁed various cellular processes.
In this context, accumulating data on mammalian septins
indicate that some such as Sept5, Sept4 and Sept2 function
not only in vesicle fusion processes [14,15] but also apoptosis
[18] and neurodegeneration [19–21], although the precise
molecular mechanisms of these processes are largely un-
known.
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